Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

Tumor Immunotherapy

Tumor Immunotherapy

Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.

Targeted Cancer Therapies

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...

Targeted Cancer Therapies

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...

Treatment Resistent Cancers

Treatment Resistent Cancers

Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...

Treatment Resistant Cancers

Treatment Resistant Cancers

Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...

Bone Marrow Sampling and Transplants

Bone Marrow Sampling and Transplants

Bone marrow transplant is a potential cure for several diseases, including cancer and specific genetic disorders. Notably, this procedure is applicable for patients suffering from aplastic anemia, certain types of leukemia, severe combined immunodeficiency disease (SCID), Hodgkin's disease, non-Hodgkin's lymphoma, multiple myeloma, thalassemia, sickle-cell disease, and certain cancers.
The transplant begins with high doses of chemotherapy and radiation treatment, which aim to destroy the...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Single-Cell RNA Analysis of Murine Osteosarcoma Uncovers Skp2 Function in Metastasis, Genomic Instability, and Immune Activation and Reveals Additional Target Pathways.

Cancer research communications·2026

Same author

Wnt5a Regulates Focal Adhesion Formation to Promote Migration in Ewing Sarcoma.

Cancers·2025

Same author

Prostate cancer in situ autovaccination with the intratumoral viral mimic poly-ICLC: Modulating the cold tumor microenvironment.

Med (New York, N.Y.)·2025

Same author

Cytokine Profiling of Children, Adolescents, and Young Adults Newly Diagnosed with Sarcomas Demonstrates the Role of IL-1β in Osteosarcoma Metastasis.

Cancers·2025

Same author

Advancing Preclinical Biology for Ewing Sarcoma: An International Effort.

Molecular cancer therapeutics·2025

Same author

Advancing Preclinical Biology for Ewing Sarcoma: An International Effort.

Molecular cancer therapeutics·2025

Search research articles

Related Experiment Video

Updated: Jun 30, 2026

Establishment of Cancer Stem Cell Cultures from Human Conventional Osteosarcoma

Establishment of Cancer Stem Cell Cultures from Human Conventional Osteosarcoma

Published on: October 14, 2016

Immunotherapy in pediatric bone sarcomas: Current progress and future directions.

Rachel Weil¹, David M Loeb¹

¹Department of Pediatrics, Department of Developmental and Molecular Biology, Cancer Dormancy Institute, Marilyn and Stanley M. Katz Institute for Immunotherapy for Cancer and Inflammatory Disorders, Albert Einstein, College of Medicine, Bronx, NY, USA.

Human Vaccines & Immunotherapeutics

|June 29, 2026

Summary

Pediatric bone sarcomas, particularly in advanced stages, show limited treatment progress. Emerging immunotherapies offer new hope by targeting the tumor microenvironment and immune system, though challenges remain.

Keywords:

Ewing sarcoma Osteosarcoma clinical trial immune checkpoint inhibitors immunotherapy innate immunity mRNA vaccines natural killer cells

More Related Videos

Establishment of Patient-Derived Xenograft Mouse Model with Human Osteosarcoma Tissues

Establishment of Patient-Derived Xenograft Mouse Model with Human Osteosarcoma Tissues

Published on: March 22, 2024

Related Experiment Videos

Last Updated: Jun 30, 2026

Establishment of Cancer Stem Cell Cultures from Human Conventional Osteosarcoma

Establishment of Cancer Stem Cell Cultures from Human Conventional Osteosarcoma

Published on: October 14, 2016

Establishment of Patient-Derived Xenograft Mouse Model with Human Osteosarcoma Tissues

Establishment of Patient-Derived Xenograft Mouse Model with Human Osteosarcoma Tissues

Published on: March 22, 2024

Area of Science:

Pediatric Oncology
Immunotherapy
Sarcoma Research

Background:

Pediatric bone sarcomas present significant therapeutic challenges, especially in metastatic or refractory cases.
Outcomes for these advanced pediatric sarcomas have seen minimal improvement over decades.
Existing multimodal therapies have not substantially altered clinical outcomes.

Purpose of the Study:

To review novel immunotherapeutic strategies for pediatric bone sarcomas.
To address challenges posed by the immunosuppressive tumor microenvironment, low mutational burden, and limited targetable antigens.
To highlight current clinical investigations and future directions in sarcoma immunotherapy.

Main Methods:

Review of current clinical investigations into various immunotherapeutic modalities.
Analysis of strategies targeting the tumor microenvironment and immune system.
Evaluation of adoptive natural killer cell therapies, cytokine-based immune priming, CAR T cell approaches, RNA-based therapeutics, and checkpoint inhibitors.

Main Results:

Multiple immunotherapeutic strategies are under active clinical investigation.
Combinations of checkpoint inhibitors with other agents are being explored.
These approaches show promise but also reveal limitations in treating pediatric sarcomas.

Conclusions:

Immunotherapy holds potential for improving outcomes in pediatric bone sarcomas.
A deeper understanding of sarcoma immune biology is crucial for developing more effective treatments.
Future strategies must overcome the unique immunological challenges of these tumors.